 |
|
|
|
|
|
|
| Article 1 to 8 out of 8 concerning Frost & Sullivan
|
-
Western European in vitro diagnostics market sustained by new technologies
(02 Jul 2008)
Market earns $12.65 billion in 2014
Despite issues such as rising R&D costs, poor reimbursement and a decline in prices, the emergence of new technologies is boosting the Western European in vitro diagnostics (IVD) markets. While the introduction of automation and integrated platforms ...
-
Pharmaceutical Industry Faces Multiple Challenges
(30 May 2005)
Future lies in Drug Pipeline Sustainability
High clinical development costs coupled with declining drug discovery success rates are causing productivity levels to fall in the global pharmaceuticals industry. The imminent patent expiry of several major blockbuster drugs and the related rise of ...
-
Strategic Analysis of European High Throughput Screening Market
(01 Nov 2004)
Pharmaceuticals and biotechnology companies are under constant pressure to discover and develop new therapeutics at a lesser cost and within shorter timeframes. However, with investments exceeding USD 500 million and nine out of ten candidates ...
-
Strategic Analysis of the World Oligonucleotides Markets
(09 Aug 2004)
Innovation Integral to Increased Adoption of Oligonucleotide Technologies
London, UK. Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan (http://pharma.frost.com) estimates that the total global market ...
-
Analysis Of The European Miniature and Sub-Miniature Pneumatic Components Market
(08 Apr 2004)
With a projected annual average growth rate of 4.4 per cent over the period between 2004 and 2009, the EUR 313.2 million mini-pneumatic components market is on course to become the fastest growing sector within the overall European pneumatic ...
-
Strategic Analysis of the World Laboratory Information Management Systems (LIMS) Markets
(08 Apr 2004)
The laboratory information management systems (LIMS) market faces the challenge of devising industry-specific and customer-oriented strategies. However, long-term success requires integration with enterprise resource planning (ERP), chromatography ...
-
Drug Discovery Companies Focus on Strong Product Line to Offset R&D Budget Slowdown
(20 Feb 2004)
One of the most persistent challenges facing manufacturers and distributors of research products is the slowed growth of R&D spending for all segments of the drug discovery market. While pharmaceutical companies are affected by slow top line growth, ...
-
LIMS/LIS Market and POCT Supplement
(20 Feb 2004)
Fuelled by the coincidence of vendor and end-user objectives of improved enterprise connectivity, the EUR172.3-million European laboratory software and systems market has entered a period of dynamic change. Budgetary myopia, however, looms as a key ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon